OXFORD, Miss., Aug. 26 Boveran Diagnostics, Inc.(OTC Bulletin Board: BOVD) today announced its Chairman was interviewed byCEOCast.com.
Mr. Welch discusses the company's cancer detection technology, the recentappointment of Nobel Prize winner Mary Mullis to its Advisory Board, and thecompany's operational plans for the future.
The interview is available at www.ceocast.com. To access the interview youwill need to register. Registration is free.
About Boveran Diagnostics, Inc.
Boveran Diagnostics, Inc. develops cancer detection technologies andmarkets this technology to pathology laboratories and other cancer diagnosticlaboratories. The Company believes that the application of automated cancerdetection technologies will provide physicians and laboratories with thegenomic information necessary to determine the presence or absence of cancerby reducing the uncertainty for the pathologist and consumer by decreasingfalse positive and false negatives resulting from current conventional cancerdiagnostic techniques. The Company's website can be found at www.boveran.com.
SEC Filings and Forward-Looking Statements
Additional information regarding Boveran Diagnostics, Inc., is containedin a Report on Form 8-K and Form 10-Q, filed with the Securities and ExchangeCommission on July 31, 2008 and August 14, 2008, respectively, by Z Yachts,Inc.
Certain statements made in this release are forward-looking statements.Forward-looking statements are based on the then-current expectations,beliefs, assumptions, estimates and forecasts about the business of BoveranDiagnostics, Inc. and the industries and markets in which Boveran Diagnostics,Inc. operates. These statements are not guarantees of future performance andinvolve risks, uncertainties and assumptions, which are difficult to predict.Therefore, actual outcomes and results may differ materially from what isexpressed or implied by these forward-looking statements. Boveran Diagnostics,Inc. expressly disclaims any intent or obligation to update theseforward-looking statements to conform the statement to actual results orchanges in the Company's expectations, except as otherwise specificallystated.
Contact: Boveran Diagnostics, Inc., 1-954-495-9334, email@example.com
SOURCE Boveran Diagnostics, Inc.